company logo

Sr. Director, Clinical Supply Management at Nektar Therapeutics in San Francisco, CA



$250K — $500K+*


Life Sciences


15+ years

Job Description

Directs all aspects of pharmaceutical drug supply and distribution, including strategic and operational leadership relative to the direction, planning, and execution of commercial and clinical trial material supply and distribution. Responsible for the providing strategic oversight for labeling, packaging, storage, distribution, disposal, and final reconciliation of products across the Nektar development pipeline of oral and parenteral dosage forms. Plans and implements activities related to the clinical material planning, material control, inventory control, and shipping/receiving and stores functions. Directs material schedules, generates and manages budgets, plans and coordinates the efficient movement of materials through development and execution of operational strategies. Collaborates cross-functionally to ensure corporate and function goals and objectives are met. This job contributes to and supports the company's research and development efforts to create high value therapeu

See More

Valid through: 7/8/2020

About Nektar Therapeutics

Nektar Therapeutics (Nektar) (NASDAQ: NKTR) is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the worlds first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough. Exubera was also recognized as the most innovative diabetes medicine of 2006 in Germany. The company is engaged in developing a propriety pipeline of drug candidates for several therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology. The companys research and development involve in small molecule and biologic drug candidates. Its drug candidate base consists of naloxegol (Movantik), a Phase III oral opioid antagonist, etirinotecan pegol, a topoisomerase inhibitor under Phase III clinical study as of 2012, NKTR 061, NKTR-181, NKTR-214, etc. In 2013, the company was assignment a patent which was developed by the company and other four co-inventors. The products of the company is served as a supplement to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability and other areas of drugs for the patients worldwide. As of March 2014, the company had an market capitalization of $1.7 billion with an enterprise value of $1.67 billion.
Total Jobs:
Average Pay:
Total value of jobs:
% Masters:
Learn More About Nektar Therapeutics
* Ladders Estimates

More Jobs at Nektar Therapeutics

Similar Jobs

More Pharmaceuticals & Biotech Jobs

Senior Process Engineer - Skin Substitute Therapeutics

$180K — $225K + $120 hourly

Confidential Company

Boston, MA 02110


Sales Manager-Chain Drug

$130K — $150K + $13K—$15K bonus + 15% company paid ira, full medical for family


Environmental Health & Safety Manager

$80K — $90K

Confidential Company

Waterloo, IA 50704

3 days ago

Find similar Clinical Director jobs: